Outset Medical, Inc.
Company Stats
- Market Cap
- $56.4M
- as of Sep 30, 2026
- Shares Outstanding
- 18.8M
- Free Float
- 73.4%
Income Statement
- Revenue
- $119.5M
- Operating Income
- -$66.7M
- Net Income
- -$81.7M
- EBITDA
- -$62.4M
- Revenue Growth, 3Y
- 1.2%
- FCF Margin, 3Y Avg
- -82.0%
- FCF Margin, Worst Year
- -103.4%
Cash Flow
- Free Cash Flow
- -$47.1M
- FCF Yield
- -83.6%
- Owner FCF Yield
- -111.3%
Balance Sheet
- Cash & Equivalents
- $35.0M
Returns & Capital
- SBC, 3Y Avg
- $27.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $119.5M | -$47.1M | -39.4% |
| FY2024 | $113.7M | -$117.2M | -103.1% |
| FY2023 | $130.4M | -$134.8M | -103.4% |
| FY2022 | $115.4M | -$154.1M | -133.5% |
| FY2021 | $102.6M | -$133.4M | -130.0% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges